One of the original aims of promaternity care in 1901 was the prevention of fits and convulsions due to eclampsia, which was often associated with pre-eclampsia. The term pre-eclampsia has been replaced in later years as eclampsia now occurs rarely.
Raised blood pressure affects the fetus as well as the mother. In the later weeks of pregnancy it may fall into one of several categories. * Chronic hypertension is present before the 20th week and has causes outside pregnancy * Pregnancy induced hypertension develops after the 20th week of pregnancy and usually resolves within 10 days after delivery * Pregnancy induced hypertension with proteinuria used to be called pre-eclampsia and occurs mostly in primigravidas * Pregnancy induced hypertension with or without proteinuria may be superimposed on chronic hypertension and this is a most dangerous combination, the effects of pregnancy being added to those of chronic hypertension * Eclampsia is a convulsive condition usually associated with proteinuric hypertension. The damaged muscle coating and intima of the spiral arteries undergoes acute atherosis, an accelerated form of arteriosclerosis that further narrows and then occludes the arterioles. A further increase in blood pressure follows, and the decrease in perfusion of the intervillous space leads commonly to intrauterine growth retardation. In hospital bed rest will be reinforced and the condition will be monitored from ultrasound measurements of the growth of the fetus, Doppler measurements of the flow in both placental bed and umbilical arteries, and cardiotocographic measurements ofvariations in the fetal heart rate. Plasma urate concentrations are the only useful biochemical indicator of deterioration, and a fall in the platelet count reflects severe disease. Antihypertensive drugs given to protect the mother's circulation, mostly against the risk of a stroke, are useful. They have no effect on the progression of the pregnancy induced hypertension but they help to maintain the pregnancy longer to allow the fetus to become more mature. These drugs tend to be kept for women whose hypertension increases despite bed rest; treatment should be started only in women who are inpatients. Hydralazine is given intravenously as first aid in acutely deteriorating hypertension. Methyldopa is still the commonest oral drug used for a few weeks. Some f blockers, such as atenolol, or combined a and 0 blockers, such as labetalol, are gaining in popularity because of their better control. The final and ultimate treatment of pregnancy induced hypertension is delivery. Induction of labour or caesarean section should be reserved until the fetus is mature enough for the neonatal facilities available, but it must be used when the condition deteriorates. Two recent changes in managing pregnancy induced hypertension in the past decade have considerably altered the outlook for mother and fetus. Firstly, use of antihypertensive drugs to allow the fetus to spread larger in the uterus has spread rapidly and widely from its epicentre in Oxford. Formerly, such drugs were thought to affect the fetus deleteriously and so their use in pregnancy was restricted. Now most obstetricians use them, and by reducing maternal risk pregnancy is prolonged by a few more weeks so that the child is more mature. Secondly, the obstetrician's reluctance to perform a caesarean section earlier in pregnancy has reduced. With improved intensive neonatal care, caesarean section as early as 26 weeks results in a reasonable chance of fetal survival. The worst effects of prolonged renal and cerebral damage are reduced for the mother and the fetus is delivered before being affected by serious chronic hypoxia in utero.
The treatment of women with severe pregnancy induced hypertension is best performed in special regional hypertension units, where neonatal and obstetric care is planned together. The Confidential Inquiries into Maternal Deaths have shown for years that each regional health authority should have one or more such designated units. A woman with or at risk of severe pregnancy induced hypertension should be admitted to such a unit to obtain the best concentrated and coordinated obstetric and neonatal care.
The future management of pregnancy induced hypertension may lie in the reduction of platelet agglutination during early pregnancy, so preventing damage of the placental bed. This might halt the whole cascade of problems. Aspirin in early pregnancy would block the cyclo-oxygenase enzymes of the platelets so that they would not be able to produce thromboxin. Recent studies have shown that low dose aspirin (75 mg a day) may be helpful in mitigating the worst effects of pregnancy induced hypertension with proteinuria.
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Eclampsia
The ultimate treatment of eclampsia is delivery Imminent eclampsia The old term fulminating pre-eclampsia is less often used, but semantics are not as important as the recognition of this severe, acute change in a woman's condition. Having had moderate or even severe pregnancy induced hypertension with proteinuria, the woman suddenly starts to produce symptoms. She may have frontal headaches and visual symptoms with jagged, angular flashes at the periphery of her visual fields and loss of vision in areas, both symptoms being due to cerebral oedema. She often has epigastric pain due to stretch of the peritoneum over the oedematous liver. In addition, some women have a curious itch confined to the mask region of the face. On examination her blood pressure may be much raised above previous readings or proteinuria may increase sharply, and she may have increased and brisk reflex reponses at knee and clonus; she needs urgent hypotensive and anticovulsant treatment. If she is at home she should be admitted under the cover of a flying squad, with intravenous diazepam and, if necessary, hydralazine running continuously. Diazepam prevents fits and reduces blood pressure.
Convulsions associated with pregnancy induced hypertension are termed eclampsia; they are very similar in form to those of epilepsy. Occasionally women in the beginning of the third trimester have eclamptic fits, having had perfectly normal blood pressure readings and urine test results within the previous few weeks at the routine visits to the antenatal clinic. Most women with eclampsia, however, give prodromal signs of pregnancy induced hypertension with proteinuria in pregnancy; the fits develop in labour or the puerperium.
The general practitioner's first move is to control the fits and prevent them causing damage to the woman. She should be laid on her side and an airway established. Intravenous diazepam is given to stop the fits, usually about 20-40 mg; this is followed by intramuscular injections (10 mg) or a continuous intravenous infusion. Recently, phenytoin has been used to prevent the recurrence of fits. In Great Britain doctors are reluctant to use magnesium sulphate, which is widely used in America and is an excellent anticonvulsant. Should the blood pressure be steeply raised, intravenous hydralazine is the best treatment either in a 5 mg bolus at 20 minutes or given intravenously as 25 mg in 500 ml of Hartmann's solution, with the drip rate titrated against the woman's blood pressure. This is best administered through a separate drip set so that anticonvulsant and antihypertension treatments can be given at different rates according to clinical needs. If the woman is in labour or induction is considered an epidural anaesthetic may be helpful, both to lower the blood pressure and to reduce the tendency to fit by removing the pain of intrauterine contractions. Any tendency of the women to have increased blood clotting should be excluded.
The ultimate treatment of eclampsia is delivery. Should eclampsia occur at home the woman must be transported to hospital by a flying squad immediately. Although rare, eclampsia still occurs in this country and in the triennium 1982-4 caused 14 maternal deaths in England and Wales.
Delivery of the infant
It must be emphasised that the ultimate cure of pregnancy induced hypertension and eclampsia is delivery. The obstetrician must weigh the answers to two often conflicting questions: * When would it be safer for the mother to be delivered? * When would it be safer for the baby to be outside the uterus in a neonatal nursery rather than on the wrong side of a failing placental exchange system? Maternal considerations may be judged by the speed of deterioration of the condition (blood pressure and proteinuria) and the expected proximity of severe complications such as eclampsia. Fetal state is best assessed by measuring the circulation supplying the fetus both in the spinal arteries Once it has been decided that it would be safer for the mother and the baby that delivery should occur the method and route of that delivery should be considered. If it is thought unsafe for the baby to undergo the contractions of labour, or if the baby is immature or in an inappropriate position, a caesarean section is indicated. If the mother's condition is deteriorating rapidly, again, the abdominal route would be swifter. If, however, the woman has a ripe cervix, the hypertensive state is not worsening rapidly, and the fetus is in an acceptable position and of reasonable maturity induction of labour should be performed with prostaglandin pessaries or membrane rupture, depending on the usage in the labour ward. An unripe cervix and a need for speedy delivery would also be grounds for a caesarean section.
Intrauterine growth retardation is associated with pregnancy induced hypertension. The two go together and share common causes. Narrowing of the placental bed vessels reduces nutrition to the fetus in pregnancy just as it would reduce available oxygen during labour. Many fetuses born to women with unmanaged pregnancy induced hypertension are small for their gestational age. Unfortunately so are many fetuses born to women who are very well managed; fetal defect therefore probably starts long before conventional management of the mother starts.
Pregnancy induced hypertension is still a major problem in antenatal medicine but many of its worst effects can be mitigated by early diagnosis from blood pressure readings at clinic visits. The future includes predictive Doppler measurements of blood flow and preventive treatment, which may include aspirin. If the condition is severe the mother's and baby's prognoses will be greatly improved if a regional hypertension in pregnancy unit is used. 
